Toxicological assessment compilation of selected examples of raw materials for homeopathic medicinal products

Toxicological assessment compilation of selected examples of raw materials for homeopathic and anthroposophic medicinal products - Part 2

The present successor article comprises more than 180 substances representing a continuative compilation of toxicologically evaluated starting materials prompted by the wide use and high number of homeopathic and anthroposophic medicinal products (HMP) on the market together with the broad spectrum of active substances of botanical, mineral, chemical or animal origin contained therein, and by the equally important requirement of applying adequate safety principles as with conventional human medicinal products in line with the European regulatory framework. The February 2019 issue of the Regulatory Toxicology and Pharmacology journal includes the antecedent article bearing the same title and entailing safety evaluations of more than 170 raw materials processed in HMP. This part 2 article highlights scientific evaluation following recognized methods used in toxicology with a view to drug-regulatory authority's assessment principles and practice in the context of HMP, and offers useful systematic, scientifically substantiated and simultaneously pragmatic approaches in differentiated HMP risk assessment. As a unique feature, both articles provide the most extensive publicly available systematic compilation of a considerable number of substances processed in HMP as a transparent resource for applicants, pharmaceutical manufacturers, the scientific community and healthcare authorities to actively support regulatory decision making in practice.

Factors related to technical management and adverse drug event reporting in independent retail pharmacies in Cali, Colombia

Independent retail pharmacies are required to have a technical manager responsible for the operation and adverse drug event reporting. In this context the following investigation is developed based on one objective: To establish factors related to the technical management and adverse drug event reporting in independent retail pharmacies in Cali. This is a cross-sectional observational study. Data was randomly collected from an estimated sample of 244 independent retail pharmacies. The results show that storage was the area of greatest implementation, 94% of the assessed pharmacies had a technical manager and 50% of them reported adverse drug events. A technical manager, being a chemist, pharmacist, or pharmacy manager, was associated with having computer equipment and dispensing homeopathic products. Adverse drug event reporting was directly associated with having bibliographic resources and inversely associated with the technical manager being a drug retailer. These data show the factors related to technical management of independent retail pharmacies and adverse drug event reporting were identified.

Study of the molybdenum dichalcogenide crystals: recent developments and novelty of the P-MoS2 structure

Nontoxicity and economic production have turned some of the molybdenum disulfide (MoS₂) polytypes into very interesting thermoelectric materials. Therefore, these materials with privileged applications have urged theoretical and experimental investigation for understanding and development of new crystals for particular applications. We present the results of computational-theoretical studies on the structural, vibrational thermoelectric, and thermodynamic properties of five crystal structures, known and newly developed, of MoS₂ based on first-principles density functional theory (DFT). While all crystals of MoS₂ were explored by undertaking several methods, the DFT method corrected for dispersion interaction (DFT-D2) confirmed the production of the cell parameters closer to the experimental. The variation of the bandgap and density of states (DOS) in all structures represents crystals comprising both semiconductors (2H- and 3R-MoS₂ crystals) and metals (1T-, P-MoS₂, and FCC-MoS₂). According to spectroscopic studies, two typical [Formula: see text] and [Formula: see text] Raman peaks are indicators of in-plane and out-of-plane vibrational modes of S atoms. From the two newly reported crystals (P-MoS₂ and FCC-MoS₂), P-MoS₂ exhibits exclusive thermoelectric properties (within 300-1000 K) such as high electrical conductivity, Seebeck coefficient, and low thermal conductivity. The thickness dependence of thermoelectric properties in 1T-, 2H-, and 3R-MoS₂ crystals is substantiated. A low thermal conductivity at room temperature along with an extremely high power factor at 1000 K exhibited by P-MoS₂ suggests P-MoS₂ crystal as a potential thermoelectric material. Finally, the present computations can introduce P-MoS₂ crystal as a new thermoelectric material with unique and extraordinary properties.

Criticality and Life-Cycle Assessment of Materials Used in Fuel-Cell and Hydrogen Technologies

The purpose of this paper is to obtain relevant data on materials that are the most commonly used in fuel-cell and hydrogen technologies. The focus is on polymer-electrolyte-membrane fuel cells, solid-oxide fuel cells, polymer-electrolyte-membrane water electrolysers and alkaline water electrolysers. An innovative, methodological approach was developed for a preliminary material assessment of the four technologies. This methodological approach leads to a more rapid identification of the most influential or critical materials that substantially increase the environmental impact of fuel-cell and hydrogen technologies. The approach also assisted in amassing the life-cycle inventories—the emphasis here is on the solid-oxide fuel-cell technology because it is still in its early development stage and thus has a deficient materials’ database—that were used in a life-cycle assessment for an in-depth material-criticality analysis. All the listed materials—that either are or could potentially be used in these technologies—were analysed to give important information for the fuel-cell and hydrogen industries, the recycling industry, the hydrogen economy, as well as policymakers. The main conclusion from the life-cycle assessment is that the polymer-electrolyte-membrane water electrolysers have the highest environmental impacts; lower impacts are seen in polymer-electrolyte-membrane fuel cells and solid-oxide fuel cells, while the lowest impacts are observed in alkaline water electrolysers. The results of the material assessment are presented together for all the considered materials, but also separately for each observed technology.

Material Risks of Homeopathic Medicinal Products: Regulatory Frameworks, Results of Preclinical Toxicology, and Clinical Meta-Analyses and Their Implications

Homeopathy is widely used and broadly accepted by health care professionals and the general public but less in academic circles. To assess possible material health risks of homeopathic medicinal products, it is necessary to identify, select, and synthesize the findings of recent reviews of controlled homeopathic clinical trials. Matching these findings with experimental data from toxicological studies helps to clarify what is known and not known about the material risks of homeopathic medicines. Rules for toxicological risk assessment and management need to be applied independently of individual attitudes towards specific therapeutic options. European regulatory bodies have developed special protocols and decision trees to assure the safety of nonindividualized homeopathic remedies. This narrative review leads to suggestions that could ease and improve toxicological decision making. No homeopathy-specific type or pattern of side effects could be extracted from the meta-analysis data. No differences in the frequency of adverse reactions between homeopathic treatment and placebo treatment could be seen, no matter whether adverse events were reported in a quantitative or a qualitative manner. Some patterns of side effects show that adverse reactions do not necessarily correlate with treatment but with the condition of the patient. Overall, the controlled clinical data available for the material risk assessment of homeopathic remedies support the statement that, if a risk exists, it must be so small that it has not yet been established. To make our risk findings useful for personal decisions regarding homeopathy, we provide a thought experiment based on four different health situations and ask the question: is homeopathy as a monotherapy or as an add-on treatment an option or should it be rejected?

Elemental impurities in pharmaceutical products adding fuel to the fire

The pharmaceuticals may generate impurities at various stages of development, transportation and storage which make them risky to be administered. Thus, it is essential that these impurities must be detected and quantified. However, their presence as impurities in finished products is virtually unavoidable, even under GMP conditions. Control of elemental impurities in pharmaceutical materials is currently undergoing a transition from control based on concentrations in components of drug products to control based on permitted daily exposures in drug products. Within the pharmaceutical community, there is uncertainty regarding the impact of these changes on manufactures of drug products. This uncertainty is fueled due to lack of publicly available information on elemental impurity levels in common pharmaceutical excipients. The present compilation gives an account of updated information about elemental impurities and reviews the regulatory aspects for such impurities in active pharmaceutical ingredients/drug formulations. In addition, the aim of this article is to review and discuss the currently used quantitative analytical method, which is used for quality control of elemental impurities in pharmaceutical products.